Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

As a cancer treatment waiting room volunteer, I’ve discovered a unique community of shared experiences and unexpected ...

Obtaining a second opinion during your cancer treatment can be a daunting but also life-changing step; however, surprisingly ...

Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort ...

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...